Rituximab

Rituximab

Rituximab is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukaemia), granulomatosis with polyangiitis and microscopic polyangiitis. Rituximab is a monoclonal antibody. It works by targeting the unwanted activity of immune cells (B cells) in rheumatoid arthritis and certain types of cancers.